Dermatology · Jefferson Valley, NY
NPI
1205884285
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3680 Hill Blvd, Mount Kisco Medical Group, PC
Jefferson Valley, NY, 10535
Phone (914) 241-1050
Groups this clinician bills Medicare through
Medicare paid, 2024
$288K
4,928 services
Medicare patients, 2024
1,217
Average age 76
Drug cost, 2024
$1.2M
1,844 prescriptions
Company payments, 2025
$181
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey P Schachne was code 99213 (office e&m - established), 1,377 times for 956 patients. In total Jeffrey P Schachne billed 4,928 services in 81 codes, and Medicare paid $288K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,377 | 956 | $72.72 | $100K |
| 17003 Destruction Skin Lesion | Office | 860 | 206 | $5.87 | $5,050 |
| 11102 Skin Biopsy | Office | 502 | 407 | $80.32 | $40K |
| 17000 Destruction Skin Lesion | Office | 420 | 317 | $48.66 | $20K |
| 99214 Office E&M - Established | Office | 265 | 223 | $104.01 | $28K |
| 11103 Skin Biopsy | Office | 240 | 141 | $46.27 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 165 | 147 | $13.60 | $2,244 |
| 99203 Office E&M - New | Office | 106 | 106 | $75.07 | $7,958 |
| 99212 Office E&M - Established | Office | 95 | 89 | $47.29 | $4,492 |
| 17110 Destruction Skin Lesion | Office | 83 | 79 | $91.60 | $7,603 |
| 17261 Destruction Skin Lesion | Office | 82 | 65 | $114.25 | $9,369 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 79 | 30 | $0.69 | $54.62 |
| 17262 Destruction Skin Lesion | Office | 61 | 47 | $144.39 | $8,808 |
| 99204 Office E&M - New | Office | 46 | 46 | $137.75 | $6,337 |
| 17281 Destruction Skin Lesion | Office | 44 | 30 | $127.09 | $5,592 |
By year: 2022 $310K for 5,088 services; 2023 $284K for 4,816 services; 2024 $288K for 4,928 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 21 | $8.65 | $199 |
| Q0112 All potassium hydroxide (koh) preparations | 15 | 15 | $4.18 | $62.7 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey P Schachne prescribed most often to Medicare patients was Ketoconazole, with 203 prescriptions and refills. In total Jeffrey P Schachne wrote 1,844 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 203 | 244 | 104 | $4,000 |
| Triamcinolone Acetonide Generic | 197 | 237 | 135 | $2,822 |
| Fluocinonide Generic | 127 | 136 | 79 | $5,969 |
| Fluorouracil Generic | 122 | 123 | 119 | $8,091 |
| Clobetasol Propionate Generic | 118 | 125 | 76 | $4,865 |
| Hydrocortisone Generic | 100 | 107 | 67 | $521 |
| Mometasone Furoate Generic | 66 | 72 | 52 | $1,551 |
| Metronidazole Generic | 56 | 62 | 35 | $2,688 |
| Dupixent Pen Dupilumab | 45 | 54 | Under 11 | $197K |
| Doxycycline Hyclate Generic | 40 | 50 | 21 | $610 |
| Tacrolimus Generic | 35 | 37 | 14 | $8,391 |
| Mupirocin Generic | 35 | 35 | 23 | $277 |
| Minoxidil Generic | 31 | 87 | Under 11 | $401 |
| Cephalexin Generic | 30 | 30 | 30 | $139 |
| Ammonium Lactate Generic | 30 | 30 | Under 11 | $887 |
Brand drugs: - claims; generic drugs: 1,543 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey P Schachne $181 ($181 in general payments such as food, travel and fees) from 3 companies. The largest payer was Galderma Laboratories, L.P. with $76.2.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.